The association between inhaled corticosteroid and osteoporosis and fracture
We read with great interest the study investigating the association between inhaled corticosteroid (ICS) and the risk of osteoporosis and fracture among COPD patients [1]. Multivariate analysis in this study demonstrated a significant dose–effect relationship between ICS and the risk of osteoporosis-related events. Compared to non-ICS users, high-dose ICS treatment was significantly associated with any osteoporosis-related event (risk ratio 1.52, 95% CI 1.24–1.62; while the corresponding estimate for low-dose ICS was 1.27, 95% CI 1.13–1.56) [1]. Overall, it is a well-designed study; however, we have one major and two minor concerns about the findings of this study.
Source: European Respiratory Journal - Category: Respiratory Medicine Authors: Wang, C.-Y., Lai, C.-C. Tags: Original Articles: Correspondence Source Type: research
More News: Chronic Obstructive Pulmonary | Corticosteroid Therapy | Orthopaedics | Osteoporosis | Respiratory Medicine | Study